Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.

about

Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study.

Item

http://www.wikidata.org/entity/Q48169834

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@en

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@nl

type

Item

label

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@en

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@nl

prefLabel

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@en

Primary systemic therapy in re ...... ng mFOLFIRINOX: A pilot study.

@nl

P1476

Primary systemic therapy in re ...... ing mFOLFIRINOX: A pilot study

@en

P2093

Blase Polite

http://www.w3.org/2001/XMLSchema#string

Chi Wang

http://www.w3.org/2001/XMLSchema#string

Daniel Catenacci

http://www.w3.org/2001/XMLSchema#string

Hedy Kindler

http://www.w3.org/2001/XMLSchema#string

Jeffrey Matthews

http://www.w3.org/2001/XMLSchema#string

Kevin Roggin

http://www.w3.org/2001/XMLSchema#string

Mark Kozloff

http://www.w3.org/2001/XMLSchema#string

Mark S Talamonti

http://www.w3.org/2001/XMLSchema#string

Marshall S Baker

http://www.w3.org/2001/XMLSchema#string

Michele Britto

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.

Pancreatic cancer and FOLFIRINOX: a new era and new questions.

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.

Pancreatic adenocarcinoma: the actual 5-year survivors.

P304

354-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24872

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Robert de W Marsh

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29044544

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5890423

http://www.w3.org/2001/XMLSchema#string